title: A patient with acute megakaryoblastic leukaemia who achieved CRi after decitabine treatment.
authors.forename: Cong
authors.initials: C
authors.lastname: Lu
authors.forename: Guangsheng
authors.initials: G
authors.lastname: He
authors.forename: Song
authors.initials: S
authors.lastname: Jin
authors.forename: Xuhui
authors.initials: X
authors.lastname: Zhang
authors.forename: Xiaohui
authors.initials: X
authors.lastname: Hu
authors.forename: Depei
authors.initials: D
authors.lastname: Wu
authors.forename: Aining
authors.initials: A
authors.lastname: Sun
authors.forename: Changgeng
authors.initials: C
authors.lastname: Ruan
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D001374:Azacitidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000077209:Decitabine; D005260:Female; D006801:Humans; D007947:Leukemia, Megakaryoblastic, Acute / Q000188:drug therapy*; D008875:Middle Aged; D012074:Remission Induction; D016896:Treatment Outcome
chemical_list: D000964:Antimetabolites, Antineoplastic; D000077209:Decitabine; D001374:Azacitidine